Why the study?
Should drug-coated balloons replace drug-eluting stents as the treatment of choice for lesions in small coronary vessels?
Should drug-coated balloons replace drug-eluting stents as the treatment of choice for lesions in small coronary vessels?
Drug-eluting stents remain the preferred treatment modality over drug-coated balloons for small coronary vessel lesions due to their proven antirestenotic efficacy.
No takes yet. Share an insight, caveat, or question.
Current evidence does not support replacing drug-eluting stents with drug-coated balloons in small vessels; dedicated randomized trials are needed.
Byrne et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: